Skip to main content
. 2021 Sep 8;19:137. doi: 10.1186/s12958-021-00826-w

Table 3.

Oocytes characteristic features before and after treatment with platelet-rich plasma (PRP) in for POSEIDON groups

Variables POSEIDON 1
Median ± IQR
POSEIDON 2
Median ± IQR
POSEIDON 3
Median ± IQR
POSEIDON 4
Median ± IQR
P-value
Total Ovocyte number Before PRP 4.00 ± 2.00 2.00 ± 3.00 1.00 ± 3.00 1.00 ± 1.00 0.003
After PRP 9.00 ± 5.00 * 5.00 ± 5.00 * 2.00 ± 7.00 * 3.00 ± 4.00 ***  < 0.001
GV Ovocyte number Before PRP 1.00 ± 2.00 0.00 ± 0.5 0.00 ± 1.00 0.00 ± 0.00 0.003
After PRP 0.00 ± 0.00 0.00 ± 1.00 0.00 ± 0.75 0.00 ± 0.00 0.085
MI Ovocyte number Before PRP 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.175
After PRP 1.00 ± 1.00 0.00 ± 1.00 0.00 ± 0.00 0.00 ± 0.00 0.007
MII Ovocyte number Before PRP 2.00 ± 3.00 2.00 ± 3.00 1.00 ± 3.00 1.00 ± 2.00 0.052
After PRP 8.00 ± 3.00 * 4.00 ± 3.50 2. .00 ± 6.50 * 2.00 ± 3.75 *** 0.001
Fetus number 17.00 ± 13.00 4.00 ± 5.00 3.00 ± 8.75 2.00 ± 6.00 0.005
Pregnancy 5/7 (71.42%) 2/17 (11.76%) 1/16 (6.25%) 6/56 (10.71%) 0.002

*: p-value < 0.05, **: p-value < 0.01, and ***: p-value < 0.001 all compare to the before level. : Fisher exact test. : Kruskal Wallis